Cargando…

DNA methylation changes in response to neoadjuvant chemotherapy are associated with breast cancer survival

BACKGROUND: Locally advanced breast cancer is a heterogeneous disease with respect to response to neoadjuvant chemotherapy (NACT) and survival. It is currently not possible to accurately predict who will benefit from the specific types of NACT. DNA methylation is an epigenetic mechanism known to pla...

Descripción completa

Detalles Bibliográficos
Autores principales:	Pedersen, Christine Aaserød, Cao, Maria Dung, Fleischer, Thomas, Rye, Morten B., Knappskog, Stian, Eikesdal, Hans Petter, Lønning, Per Eystein, Tost, Jörg, Kristensen, Vessela N., Tessem, May-Britt, Giskeødegård, Guro F., Bathen, Tone F.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2022
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9233373/ https://www.ncbi.nlm.nih.gov/pubmed/35751095 http://dx.doi.org/10.1186/s13058-022-01537-9

Ejemplares similares

Integrative metabolic and transcriptomic profiling of prostate cancer tissue containing reactive stroma
por: Andersen, Maria K., et al.
Publicado: (2018)

High PTEN gene expression is a negative prognostic marker in human primary breast cancers with preserved p53 function
por: Yndestad, Synnøve, et al.
Publicado: (2017)

Prognostic value of metabolic response in breast cancer patients receiving neoadjuvant chemotherapy
por: Cao, Maria D, et al.
Publicado: (2012)

Gene signatures ESC, MYC and ERG-fusion are early markers of a potentially dangerous subtype of prostate cancer
por: Rye, Morten Beck, et al.
Publicado: (2014)

A Balanced Tissue Composition Reveals New Metabolic and Gene Expression Markers in Prostate Cancer
por: Tessem, May-Britt, et al.
Publicado: (2016)

Spatial differentiation of metabolism in prostate cancer tissue by MALDI-TOF MSI
por: Andersen, Maria K., et al.
Publicado: (2021)

Aromatase inhibition 2013: clinical state of the art and questions that remain to be solved
por: Lønning, Per Eystein, et al.
Publicado: (2013)

BRCA1 methylation in newborns: genetic disposition, maternal transfer, environmental influence, or by chance only?
por: Lønning, Per Eystein, et al.
Publicado: (2018)

Spermine and Citrate as Metabolic Biomarkers for Assessing Prostate Cancer Aggressiveness
por: Giskeødegård, Guro F., et al.
Publicado: (2013)

TP53 status predicts long-term survival in locally advanced breast cancer after primary chemotherapy
por: Eikesdal, Hans P., et al.
Publicado: (2014)

Cholesterol synthesis pathway genes in prostate cancer are transcriptionally downregulated when tissue confounding is minimized
por: Rye, Morten Beck, et al.
Publicado: (2018)

Metabolic markers in blood can separate prostate cancer from benign prostatic hyperplasia
por: Giskeødegård, Guro F, et al.
Publicado: (2015)

Constitutional Mosaic Epimutations - a hidden cause of cancer?
por: Lønning, Per E., et al.
Publicado: (2019)

Effects of concomitant inactivation of p53 and pRb on response to doxorubicin treatment in breast cancer cell lines
por: Huun, Johanna, et al.
Publicado: (2017)

ramr: an R/Bioconductor package for detection of rare aberrantly methylated regions
por: Nikolaienko, Oleksii, et al.
Publicado: (2021)

epialleleR: an R/Bioconductor package for sensitive allele-specific methylation analysis in NGS data
por: Nikolaienko, Oleksii, et al.
Publicado: (2023)

Serum Levels of Choline-Containing Compounds Are Associated with Aerobic Fitness Level: The HUNT-Study
por: Bye, Anja, et al.
Publicado: (2012)

The genes controlling normal function of citrate and spermine secretion are lost in aggressive prostate cancer and prostate model systems
por: Rye, Morten Beck, et al.
Publicado: (2022)

SFRP4 gene expression is increased in aggressive prostate cancer
por: Sandsmark, Elise, et al.
Publicado: (2017)

Effect of the MDM2 promoter polymorphisms SNP309T>G and SNP285G>C on the risk of ovarian cancer in BRCA1 mutation carriers
por: Bjørnslett, Merete, et al.
Publicado: (2012)

Simultaneous Detection of Zinc and Its Pathway Metabolites Using MALDI MS Imaging of Prostate Tissue
por: Andersen, Maria K., et al.
Publicado: (2020)

Metabolic Portraits of Breast Cancer by HR MAS MR Spectroscopy of Intact Tissue Samples
por: Haukaas, Tonje H., et al.
Publicado: (2017)

Activation of Akt characterizes estrogen receptor positive human breast cancers which respond to anthracyclines
por: Yndestad, Synnøve, et al.
Publicado: (2017)

Adjuvant treatment: the contribution of expression microarrays
por: Lønning, Per Eystein, et al.
Publicado: (2007)

Alterations of the retinoblastoma gene in metastatic breast cancer
por: Berge, Elisabet Ognedal, et al.
Publicado: (2011)

Estrogens Correlate with PELP1 Expression in ER Positive Breast Cancer
por: Flågeng, Marianne Hauglid, et al.
Publicado: (2015)

The novel microRNAs hsa-miR-nov7 and hsa-miR-nov3 are over-expressed in locally advanced breast cancer
por: Poduval, Deepak, et al.
Publicado: (2020)

Correction: The novel microRNAs hsa-miR-nov7 and hsa-miR-nov3 are over-expressed in locally advanced breast cancer
por: Poduval, Deepak, et al.
Publicado: (2021)

An optimized MALDI MSI protocol for spatial detection of tryptic peptides in fresh frozen prostate tissue
por: Høiem, Therese S., et al.
Publicado: (2022)

Inverse Regulation of EGFR/HER1 and HER2-4 in Normal and Malignant Human Breast Tissue
por: Flågeng, Marianne Hauglid, et al.
Publicado: (2013)

Quantitative DNA methylation analyses reveal stage dependent DNA methylation and association to clinico-pathological factors in breast tumors
por: Klajic, Jovana, et al.
Publicado: (2013)

Identification of metabolites from 2D (1)H-(13)C HSQC NMR using peak correlation plots
por: Öman, Tommy, et al.
Publicado: (2014)

FunHoP: Enhanced Visualization and Analysis of Functionally Homologous Proteins in Complex Metabolic Networks
por: Rise, Kjersti, et al.
Publicado: (2021)

FunHoP analysis reveals upregulation of mitochondrial genes in prostate cancer
por: Rise, Kjersti, et al.
Publicado: (2022)

Association of serum metabolome profile with the risk of breast cancer in participants of the HUNT2 study
por: Mrowiec, Katarzyna, et al.
Publicado: (2023)

Elevated levels of the steroidogenic factor 1 are associated with over-expression of CYP19 in an oestrogen-producing testicular Leydig cell tumour
por: Straume, Anne Hege, et al.
Publicado: (2012)

MDM2 promoter SNP285 and SNP309; phylogeny and impact on cancer risk
por: Knappskog, Stian, et al.
Publicado: (2011)

Chemosensitivity and p53; new tricks by an old dog
por: Lønning, Per E, et al.
Publicado: (2012)

Changes to Intermediary Metabolites in Sporadic and LRRK2 Parkinson's Disease Demonstrated by Proton Magnetic Resonance Spectroscopy
por: Aasly, Jan O., et al.
Publicado: (2015)

Metabolic characterization of triple negative breast cancer
por: Cao, Maria D, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_rdq9akc6c0mqc710ftca0mss1c